Unsupervised proteome analysis of human leukaemia cells identifies the Valosin-containing protein as a putative marker for glucocorticoid resistance

Leukemia

Volumn 20, Issue 5, 2006, Pages 820-826

  Lauten, Melchior ^a,c   Schrauder, A ^b   Kardinal, C ^c   Harbott, J ^d   Welte, K ^c   Schlegelberger, B ^c   Schrappe, M ^b   von Neuhoff, N ^c  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF KIEL   (Germany)

^c HANNOVER MEDICAL SCHOOL   (Germany)

^d JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

Acute lymphoblastic leukaemia; Childhood; Glucocorticoid resistance; Proteomics; Valosin containing protein

Indexed keywords

CATALASE; G PROTEIN COUPLED RECEPTOR; GLUCOCORTICOID; MALATE DEHYDROGENASE; PREDNISONE; PROTEOME;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; BLOOD ANALYSIS; CANCER RESISTANCE; CASE CONTROL STUDY; CELL INFILTRATION; CHILD; CHILDHOOD LEUKEMIA; CLINICAL ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EFFICACY; DRUG RESPONSE; FEMALE; HUMAN; HUMAN CELL; LEUKEMIA CELL; MALE; MULTICENTER STUDY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN DEGRADATION; PROTEIN DETERMINATION; PROTEIN EXPRESSION; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; TWO DIMENSIONAL GEL ELECTROPHORESIS; VALIDATION STUDY; WESTERN BLOTTING;

EID: 33646137799     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/sj.leu.2404162     Document Type: Article

References (43)

1. Riehm H, Reiter A, Schrappe M, Berthold F, Dopfer R, Gerein V et al. Corticosteroid-dependent reduction of leukocyte count in blood as a prognostic factor in acute lymphoblastic leukemia in childhood (therapy study ALL-BFM 83). Klin Padiatr 1987; 199: 151-160.
2. Reiter A, Schrappe M, Ludwig WD, Hiddemann W, Sauter S, Henze G et al. Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients. Results and conclusions of the multicenter trial ALL-BFM 86. Blood 1994; 84: 3122-3133.
3. Schrappe M, Reiter A, Ludwig W-D, Harbott J, Zimmermann M, Hiddemann W et al. Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: Results of trial ALL-BFM 90. German-Austrian-Swiss ALL-BFM Study Group. Blood 2000; 95: 3310-3322.
4. Lauten M, Stanulla M, Zimmermann M, Welte K, Riehm H, Schrappe M. Clinical outcome of patients with childhood acute lymphoblastic leukaemia and an initial leukaemic blood blast count of less than 1000 per microliter. Klin Padiatr 2001; 213: 169-174.
5. Bahr MJ, Vincent KJ, Arthur MJ, Fowler AV, Smart DE, Wright MC et al. Control of the tissue inhibitor of metalloproteinases-1 promoter in culture-activated rat hepatic stellate cells: Regulation by activator protein-1 DNA binding proteins. Hepatology 1999; 29: 839-848.
6. Dignam JD, Lebovitz RM, Roeder RG. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res 1983; 11: 1475-1489.
7. Blum H, Beier H, Gross HJ. Improved silver staining of plant proteins, RNA and DNA in polyacrylamide gels. Electrophoresis 1987; 8: 93-99.
8. Kasugai I, Yamada M. High production of catalase in hydrogen peroxide-resistant human leukemia HL-60 cell lines. Leuk Res 1992; 16: 173-179.
9. Fagioli M, Alcalay M, Tomassoni L, Ferrucci P, Mencarelli A, Riganelli D et al. Cooperation between the RING+B1-B2 and coiled-coil domains of PML is necessary for its effects on cell survival. Oncogene 1998; 16: 2905-2913.
10. Yamamoto S, Tomita Y, Hoshida Y, Takiguchi S, Fujiwara Y, Yasuda T et al. Expression level of valosin-containing protein is strongly associated with progression and prognosis of gastric carcinoma. J Clin Oncol 2003; 21: 2537-2544.
11. Senga T, Iwamoto S, Yoshida T, Yokota T, Adachi K, Azuma E et al. LSSIG is a novel murine leukocyte-specific GPCR that is induced by the activation of STAT3. Blood 2003; 101: 1185-1187.
12. Volm M, Zintl F, Edler L, Sauerbrey A. Prognostic value of protein kinase C, proto-oncogene products and resistance-related proteins in newly diagnosed childhood acute lymphoblastic leukemia. Med Pediatr Oncol 1997; 28: 117-126.
13. Povey S, Jeremiah S, Arthur E, Ber R, Fialkow P, Gardiner E et al. Deficiency of malic enzyme: A possible marker for malignancy in lymphoid cells. Ann Hum Genet 1981; 45(Part 3): 237-252.
14. Asai T, Tomita Y, Nakatsuka S, Hoshida Y, Myoui A, Yoshikawa H et al. VCP (p97) regulates NFkappaB signaling pathway, which is important for metastasis of osteosarcoma cell line. Jpn J Cancer Res 2002; 93: 296-304.
15. Tsujimoto Y, Tomita Y, Hoshida Y, Kono T, Oka T, Yamamoto S et al. Elevated expression of valosin-containing protein (p97) is associated with poor prognosis of prostate cancer. Clin Cancer Res 2004; 10: 3007-3012.
16. Yamamoto S, Tomita Y, Hoshida Y, Iizuka N, Kidogami S, Miyata H et al. Expression level of valosin-containing protein (p97) is associated with prognosis of esophageal carcinoma. Clin Cancer Res 2004; 10: 5558-5565.
17. Yamamoto S, Tomita Y, Hoshida Y, Iizuka N, Monden M, Yamamoto S et al. Expression level of valosin-containing protein (p97) is correlated with progression and prognosis of non-smallcell lung carcinoma. Ann Surg Oncol 2004; 11: 697-704.
18. Yamamoto S, Tomita Y, Nakamori S, Hoshida Y, Nagano H, Dono K et al. Elevated expression of valosin-containing protein (p97) in hepatocellular carcinoma is correlated with increased incidence of tumor recurrence. J Clin Oncol 2003; 21: 447-452.
19. Yamamoto S, Tomita Y, Hoshida Y, Nagano H, Dono K, Umeshita K et al. Increased expression of valosin-containing protein (p97) is associated with lymph node metastasis and prognosis of pancreatic ductal adenocarcinoma. Ann Surg Oncol 2004; 11: 165-172.
20. Yamamoto S, Tomita Y, Hoshida Y, Toyosawa S, Inohara H, Kishino M et al. Expression level of valosin-containing protein (VCP) as a prognostic marker for gingival squamous cell carcinoma. Ann Oncol 2004; 15: 1432-1438.
21. Pui CH, Costlow ME, Kalwinsky DK, Dahl GV. Glucocorticoid receptors in childhood acute non-lymphocytic leukemia. Leuk Res 1983; 7: 11-16.
22. Sousa AR, Lane SJ, Cidlowski JA, Staynov DZ, Lee TH. Glucocorticoid resistance in asthma is associated with elevated in vivo expression of the glucocorticoid receptor beta-isoform. J Allergy Clin Immunol 2000; 105: 943-950.
23. Kaspers GJ, Pieters R, Veerman AJ. Glucocorticoid resistance in childhood leukemia. Int J Pediatr Hematol/Oncol 1997; 4: 583-596.
24. Shahidi H, Vottero A, Stratakis CA, Taymans SE, Karl M, Longui CA et al. Imbalanced expression of the glucocorticoid receptor isoforms in cultured lymphocytes from a patient with systemic glucocorticoid resistance and chronic lymphocytic leukemia. Biochem Biophys Res Commun 1999; 254: 559-565.
25. Lauten M, Beger C, Gerdes K, Asgedom G, Kardinal C, Welte K et al. Expression of heat-shock protein 90 in glucocorticoidsensitive and -resistant childhood acute lymphoblastic leukaemia. Leukemia 2003; 17: 1551-1556.
26. Lauten M, Cario G, Asgedom G, Welte K, Schrappe M. Protein expression of the glucocorticoid receptor in childhood acute lymphoblastic leukemia. Haematologica 2003; 88: 1253-1258.
27. Koper JW, Stolk RP, de Lange P, Huizenga NA, Molijn GJ, Pols HA et al. Lack of association between five polymorphisms in the human glucocorticoid receptor gene and glucocorticoid resistance. Hum Genet 1997; 99: 663-668.
28. Anderer G, Schrappe M, Brechlin AM, Lauten M, Muti P, Welte K et al. Polymorphisms within glutathione S-transferase genes and initial response to glucocorticoids in childhood acute lymphoblastic leukaemia. Pharmacogenetics 2000; 10: 715-726.
29. Lauten M, Matthias T, Stanulla M, Beger C, Welte K, Schrappe M. Association of initial response to prednisone treatment in childhood acute lymphoblastic leukaemia and polymorphisms within the tumour necrosis factor and the interleukin-10 genes. Leukemia 2002; 16: 1437-1442.
30. Dittmar KD, Demady DR, Stancato LF, Krishna P, Pratt WB. Folding of the glucocorticoid receptor by the heat shock protein (hsp) 90-based chaperone machinery. The role of p23 is to stabilize receptor.hsp90 heterocomplexes formed by hsp90.p60.hsp70. J Biol Chem 1997; 272: 21213-21220.
31. Kofler R, Schmidt S, Kofler A, Ausserlechner MJ. Resistance to glucocorticoid-induced apoptosis in lymphoblastic leukemia. J Endocrinol 2003; 178: 19-27.
32. Rabilloud T. Two-dimensional gel electrophoresis in proteomics: Old, old fashioned, but it still climbs up the mountains. Proteomics 2002; 2: 3-10.
33. Zhong X, Shen Y, Ballar P, Apostolou A, Agami R, Fang S. AAA ATPase p97/ valosin-containing protein interacts with gp78, a ubiquitin ligase for endoplasmic reticulum-associated degradation. J Biol Chem 2004; 279: 45676-45684.
34. Regala R, Weems C, Jamieson L, Copland J, Thompson E, Fields A. Atypical protein kinase Ciota plays a critical role in human lung cancer cell growth and tumorigenicity. J Biol Chem 2005; 280: 31109-31115.
35. Lo A, Liew C, Ngai S, Tsui S, Fung K, Lee C et al. Developmental regulation and cellular distribution of human cytosolic malate dehydrogenase (MDH1). J Cell Biochem 2005; 94: 763-773.
36. Song C, Wang Q, Li CC. ATPase activity of p97-valosin-containing protein (VCP). D2 mediates the major enzyme activity, and D1 contributes to the heat-induced activity. J Biol Chem 2003; 278: 3648-3655.
37. Yamamoto S, Tomita Y, Hoshida Y, Sakon M, Kameyama M, Imaoka S et al. Expression of valosin-containing protein in colorectal carcinomas as a predictor for disease recurrence and prognosis. Clin Cancer Res 2004; 10: 651-657.
38. Pleasure IT, Black MM, Keen JH. Valosin-containing protein, VCP, is a ubiquitous clathrin-binding protein. Nature 1993; 365: 459-462.
39. Cao K, Zheng Y. The Cdc48/p97-Ufd1-Npl4 complex: Its potential role in coordinating cellular morphogenesis during the M-G1 transition. Cell Cycle 2004; 3: 422-424.
40. Ye Y, Meyer HH, Rapoport TA. Function of the p97-Ufd1-Npl4 complex in retrotranslocation from the ER to the cytosol: Dual recognition of nonubiquitinated polypeptide segments and polyubiquitin chains. J Cell Biol 2003; 162: 71-84.
41. Bachmann PS, Gorman R, Mackenzie KL, Lutze-Mann L, Lock RB. Dexamethasone resistance in B-cell precursor childhood acute lymphoblastic leukemia occurs downstream of ligand-induced nuclear translocation of the glucocorticoid receptor. Blood 2005; 105: 2519-2526.
42. Tissing WJE, Meijerink JP, den Boer ML, Brinkhof B, Pieters R. mRNA expression levels of (co)chaperone molecules of the glucocorticoid receptor are not involved in glucocorticoid resistance in pediatric ALL. Leukemia 2005; 19: 727-733.
43. Cario G, Stanulla M, Fine BM, Teuffel O, N VN, Schrauder A et al. Distinct gene expression profiles determine molecular treatment response in childhood acute lymphoblastic leukemia. Blood 2004; 105: 821-826.